newsfilter
← Latest News
Business Wire·

PhaseBio Pharmaceuticals to Participate in the 21st Annual Needham Healthcare Conference

PhaseBio Pharmaceuticals, Inc. (NASDAQ:PHAS), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapies for cardiovascular diseases, today announced that Chief Financial Officer John Sharp will partic